Market Tracker

02/09 5:16pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

7.28
Delayed Data
As of Feb 09
 -0.04 / -0.55%
Today’s Change
7.00
Today|||52-Week Range
25.25
-57.99%
Year-to-Date

Today’s Trading

Previous close7.32
Today’s open7.11
Day’s range7.00 - 7.53
Volume1,366,233
Average volume (3 months)1,422,025
Market cap$937.1M
Dividend yield--
Data as of 4:00pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+34.74%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book22.25

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd+0.56+5.89%
MCRBSeres Therapeutics I...-0.96-4.13%
FPRXFive Prime Therapeut...-0.12-0.41%
MNTAMomenta Pharmaceutic...-0.17-1.55%
Data as of 4:01pm ET, 02/09/2016

Financials

Next reporting dateMarch 1, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts